<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Pharmalicensing.com: PR Newswire: Joint Ventures</title>
		<link>http://pharmalicensing.com/rss/</link>
		<description>Latest market and business intelligence from the leading publishers worldwide.</description>
		<language>en-us</language>
		<image>
			<title>Pharmalicensing.com: PR Newswire: Joint Ventures</title>
			<link>http://pharmalicensing.com/rss/</link>
			<url>http://pharmalicensing.com/images/pharmalicensing_logo.gif</url>
			<width>144</width>
		</image>
									<item>
				<title>Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation</title>
				<description>STOCKHOLM, November 20 /PRNewswire/ -- Karolinska Development AB today announced that the European Investment
Fund (EIF) has entered into a co-investment agreement with the company. The
co-investment...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4027</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4027</guid>
				<pubDate>Fri, 20 Nov 2009 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>New Consortium Paves the way for Improved Treatment of Hypertension and Associated Vascular Complications</title>
				<description>LEIDEN, The Netherlands, November 17 /PRNewswire/ -- Top Institute Pharma (TI Pharma) has formed a
consortium with Actelion Pharmaceuticals Ltd, Erasmus Medical Centre and
Maastricht University to...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3997</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3997</guid>
				<pubDate>Tue, 17 Nov 2009 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>GSMA and the University of Manchester to Establish an m-Health Innovation Centre</title>
				<description>LONDON, November 11 /PRNewswire/ -- The GSMA, which represents the interests of the worldwide mobile
communications industry, today announced that it has signed a Memorandum of
Understanding with the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3963</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3963</guid>
				<pubDate>Wed, 11 Nov 2009 09:00:00 +0000</pubDate>
			</item>
					<item>
				<title>See the Benefits of a Healthy Lifestyle</title>
				<description>ANDOVER, England, November 9 /PRNewswire/ -- Sight charity The Eyecare Trust has joined forces with healthcare
provider Simplyhealth to warn that many lifestyle choices can pose a serious
threat to...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3946</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3946</guid>
				<pubDate>Mon, 09 Nov 2009 00:01:00 +0000</pubDate>
			</item>
					<item>
				<title>Bicycle Therapeutics and Pepscan Enter Into Partnership to Apply Constrained Peptide Technology in the Development of Novel Biotherapeutics</title>
				<description>CAMBRIDGE, England and LELYSTAD, The Netherlands, November 2 /PRNewswire/ -- Bicycle Therapeutics has obtained a global license from Pepscan to
utilize its proprietary constrained peptide chemistry...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3917</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3917</guid>
				<pubDate>Mon, 02 Nov 2009 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group</title>
				<description>NEW BRUNSWICK, New Jersey, November 2 /PRNewswire/ -- In a joint statement, Czura Thornton&#039;s founders Tony Czura and Nick
Thornton said: &quot;We are delighted to augment our Life Sciences Group...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3916</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3916</guid>
				<pubDate>Mon, 02 Nov 2009 13:15:00 +0000</pubDate>
			</item>
					<item>
				<title>Nuevolution Announces Receipt of Milestone Payment From Merck &amp; Co., Inc.</title>
				<description>COPENHAGEN, November 2 /PRNewswire/ -- Nuevolution A/S today announced that it has received a milestone payment 
derived from its collaboration with Merck &amp; Co. Inc., Whitehouse Station, NJ.

    The...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3911</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3911</guid>
				<pubDate>Mon, 02 Nov 2009 09:49:00 +0000</pubDate>
			</item>
					<item>
				<title>InteRNA Technologies and Dana-Farber Cancer Institute to Collaborate on the Role of microRNAs in Cancer Pathways</title>
				<description>UTRECHT, The Netherlands, November 2 /PRNewswire/ -- InteRNA Technologies B.V. and the Dana-Farber Cancer Institute 
(Boston, USA) have entered into a research agreement to develop microRNA...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3910</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3910</guid>
				<pubDate>Mon, 02 Nov 2009 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>London Genetics Focuses on Partnering Following Successful Pharmacogenetics Conference</title>
				<description>LONDON, October 30 /PRNewswire/ -- London Genetics Limited, an expert in the use of
pharmacogenetics in clinical drug discovery and development, has entered an
intensive partnering programme...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3904</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3904</guid>
				<pubDate>Fri, 30 Oct 2009 15:23:00 +0000</pubDate>
			</item>
					<item>
				<title>Clinical Genomics Continues Collaborative Research With CSIRO</title>
				<description>SYDNEY, October 7 /PRNewswire/ -- Sydney-based Clinical Genomics Pty Ltd and CSIRO have entered into a new
phase in their collaboration to develop improved diagnostics for cancers of
the colon and...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3773</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3773</guid>
				<pubDate>Wed, 07 Oct 2009 07:38:00 +0000</pubDate>
			</item>
					<item>
				<title>CSC and Cordys Establish Strategic Global Partnership</title>
				<description>PUTTEN, The Netherlands, and FALLS CHURCH, Virginia, October 6 /PRNewswire/ -- CSC (NYSE: CSC), a global leader in technology-enabled solutions and
services, and Cordys, a leading provider of...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3768</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3768</guid>
				<pubDate>Tue, 06 Oct 2009 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Children&#039;s Hospital in Colorado Rounds off List of 24 Cord Blood Transplant Centers Worldwide Enrolling for ExCell Trial Studying StemEx(R) for Leukemia and Lymphoma</title>
				<description>DENVER, Colorado and JERUSALEM, September 16 /PRNewswire/ -- Children&#039;s Hospital of Colorado and the Gamida Cell-Teva Joint Venture
announced today that Children&#039;s Hospital is enrolling patients for...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3653</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3653</guid>
				<pubDate>Wed, 16 Sep 2009 12:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Helsinn Partners With Eisai for Gelclair in Italy</title>
				<description>LUGANO, Switzerland, September 15 /PRNewswire/ -- The Swiss pharmaceutical group Helsinn and Eisai Italy,
subsidiary of the Japanese pharmaceutical company, have signed a licensing
agreement for the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3641</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3641</guid>
				<pubDate>Tue, 15 Sep 2009 12:05:00 +0000</pubDate>
			</item>
					<item>
				<title>Pieris AG Enters into Anticalin Collaboration With Allergan, Inc.</title>
				<description>FREISING-WEIHENSTEPHAN, Germany, September 15 /PRNewswire/ -- Pieris AG today announced that they have entered into a collaboration
agreement with Allergan, Inc. (NYSE: AGN) that combines Pieris&#039;...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3639</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3639</guid>
				<pubDate>Tue, 15 Sep 2009 09:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Tosho&#039;s Satisfaction With Health Robotics Steers the Japanese Pharmacy Automation Leader to Renew and to Expand its I.V. Automation Strategic Partnership</title>
				<description>BOZEN, Sud-Tyrol, Italy, September 12 /PRNewswire/ -- Health Robotics today announced that after a successful first year of
cooperation in Japan with Tosho Inc., the companies signed this week...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3622</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3622</guid>
				<pubDate>Sat, 12 Sep 2009 18:58:00 +0000</pubDate>
			</item>
					<item>
				<title>Tosho&#039;s Satisfaction With Health Robotics Steers the Japanese Pharmacy Automation Leader to Renew and to Expand its I.V. Automation Strategic Partnership</title>
				<description>BOZEN, Italy, September 7 /PRNewswire/ -- Health Robotics today announced that after a successful first year of
cooperation in Japan with Tosho Inc., the companies signed this week a
contract renewal...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3587</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3587</guid>
				<pubDate>Mon, 07 Sep 2009 14:57:00 +0000</pubDate>
			</item>
					<item>
				<title>Nucletron Increases Full Year Outlook After Strong First Half 2009</title>
				<description>VEENENDAAL, the Netherlands, September 3 /PRNewswire/ -- Nucletron, a global leader in radiation oncology, today announced strong
financial results over the first half year of 2009. Despite...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3573</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3573</guid>
				<pubDate>Thu, 03 Sep 2009 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>SynCo Bio Partners Enters the Japanese Market as it Signs its First Agreement With a Japanese Pharmaceutical Company</title>
				<description>AMSTERDAM, September 1 /PRNewswire/ -- SynCo Bio Partners B.V., the expert in long term GMP contract
manufacturing of biopharmaceuticals announced today that it has expanded its
business into a new...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3551</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3551</guid>
				<pubDate>Tue, 01 Sep 2009 09:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Team Garmin-Slipstream Announces POM Wonderful Sponsorship</title>
				<description>LOS ANGELES, August 31 /PRNewswire/ -- POM Wonderful, the largest U.S. grower of Wonderful variety pomegranates
and maker of 100% pomegranate juice, today announced its sponsorship of...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3544</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3544</guid>
				<pubDate>Mon, 31 Aug 2009 14:29:00 +0000</pubDate>
			</item>
					<item>
				<title>Nuevolution Announces New Research Collaboration With Big Pharma</title>
				<description>COPENHAGEN, August 31 /PRNewswire/ -- Nuevolution A/S today announced that it has entered into a drug discovery 
collaboration with Novartis.

    During the collaboration, Nuevolution will apply...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3537</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3537</guid>
				<pubDate>Mon, 31 Aug 2009 09:00:00 +0000</pubDate>
			</item>
					<item>
				<title>New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of PLAVIX(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty</title>
				<description>PARIS, and PRINCETON, New Jersey, August 30 /PRNewswire/ -- -No added benefit on the composite primary end-point with the higher
dose when entire ACS study population considered-

    -Important new...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3531</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3531</guid>
				<pubDate>Sun, 30 Aug 2009 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Cardea Technology Inc and Optasia Medical Ltd Announce Plans to Collaborate to Optimize Their Vertebral Fracture Assessment Tools</title>
				<description>BOSTON, Massachusetts and CHEADLE, England, August 27 /PRNewswire/ -- Cardea Technology, Inc. and Optasia Medical Ltd., announce plans to
collaborate and configure their software tools for Vertebral...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3523</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3523</guid>
				<pubDate>Thu, 27 Aug 2009 16:06:00 +0000</pubDate>
			</item>
					<item>
				<title>Shire Builds Competitive Position of its HGT Business through Research Collaboration with Santaris Pharma A/S on LNA Drug Platform</title>
				<description>CAMBRIDGE, Massachusetts, August 24 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces today that it has entered into a
research-based...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3502</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3502</guid>
				<pubDate>Mon, 24 Aug 2009 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Nanosyn, Inc. and PCAS Announce the Signing of a Joint-Venture Agreement to Operate PCAS-NANOSYN, LLC</title>
				<description>LONGJUMEAU, PARIS and MENLO PARK, California, August 12 /PRNewswire/ -- PCAS, a worldwide leader in commercial scale pharmaceutical synthesis and
fine and specialty chemical manufacturing, and...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3462</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3462</guid>
				<pubDate>Wed, 12 Aug 2009 13:11:00 +0000</pubDate>
			</item>
					<item>
				<title>Fenwal and Golden Meditech Agree to Form Joint Venture in China for Blood Collection and Transfusion Technologies</title>
				<description>HONG KONG and LAKE ZURICH, Illinois, August 12 /PRNewswire/ -- Fenwal, Inc. of Lake Zurich, Illinois, and Golden Meditech (stock code:
801.HK) of Hong Kong, announced today they have agreed to form a...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3460</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3460</guid>
				<pubDate>Wed, 12 Aug 2009 01:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Alticor Enters Into Joint Venture Agreement With Metagenics</title>
				<description>ADA, Michigan and SAN CLEMENTE, California, August 11 /PRNewswire/ -- Alticor, a global company with an uncompromising commitment to innovative
scientific research and development of quality...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3458</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3458</guid>
				<pubDate>Tue, 11 Aug 2009 19:40:00 +0000</pubDate>
			</item>
					<item>
				<title>Nuevolution Announces Worldwide Technology Cross-Licensing Agreement With GSK</title>
				<description>COPENHAGEN, Denmark, July 28 /PRNewswire/ -- Nuevolution today announced the execution of a worldwide
technology cross-licensing agreement with GlaxoSmithKline.

    The agreement relates to a number...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3417</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3417</guid>
				<pubDate>Tue, 28 Jul 2009 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Health Robotics Announces American Joint Venture With i.v.SOFT</title>
				<description>BOZEN, Italy, July 27 /PRNewswire/ -- Health Robotics today announced that it has embarked in a joint venture
with i.v.SOFT in order to market, implement, and support its I.V. Workflow
Engine and...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3411</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3411</guid>
				<pubDate>Mon, 27 Jul 2009 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Cellestis Appoints BioChemMack as New Commercial Partner in Russia</title>
				<description>MOSCOW, July 23 /PRNewswire/ -- Cellestis is pleased to introduce BioChemMack (Moscow, Russia) as its
newly appointed commercial partner for distribution of the tuberculosis blood
test,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3401</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3401</guid>
				<pubDate>Thu, 23 Jul 2009 08:19:00 +0000</pubDate>
			</item>
					<item>
				<title>University of Lodz Invests in the Unique Cellaxess(R)HT System for Research on Multidrug Resistance Genes in Cancer</title>
				<description>GOTHENBURG, Sweden, July 22 /PRNewswire/ -- Cellectricon, a leading provider of cell-based screening solutions for
research and drug discovery, today announced its collaboration with
University of...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3396</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3396</guid>
				<pubDate>Wed, 22 Jul 2009 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus</title>
				<description>ROCKVILLE, Maryland and LONDON, July 20 /PRNewswire/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) and GlaxoSmithKline PLC (GSK)
today announced that BENLYSTA(TM) (belimumab, formerly...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3388</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3388</guid>
				<pubDate>Mon, 20 Jul 2009 05:01:00 +0000</pubDate>
			</item>
					<item>
				<title>Finesse Solutions Forges Agreement With Leading Biotechnology Company for Single-Use Technology Exploration</title>
				<description>SAN JOSE, California, July 13 /PRNewswire/ -- Finesse Solutions, LLC, San Jose, CA, a manufacturer of measurement and
control solutions for biologics applications today announced a...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3356</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3356</guid>
				<pubDate>Mon, 13 Jul 2009 17:05:00 +0000</pubDate>
			</item>
					<item>
				<title>Health Robotics Expands and Diversifies Global Channel Strategies With Joint-Ventures &amp;amp; Direct Operations</title>
				<description>BOZEN, Italy, July 13 /PRNewswire/ -- Health Robotics today announced that it has decided to complement its
successful indirect channel strategies with direct investments in local
infrastructure at a...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3355</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3355</guid>
				<pubDate>Mon, 13 Jul 2009 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Sirius Genomics Announces New Collaboration With Assistance Publique-Hopitaux de Paris</title>
				<description>VANCOUVER, Canada, July 13 /PRNewswire/ -- Sirius Genomics, a developer of pharmacogenomic diagnostics, announced 
today that it has signed a collaborative agreement with the Assistance...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3352</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3352</guid>
				<pubDate>Mon, 13 Jul 2009 10:00:00 +0000</pubDate>
			</item>
					<item>
				<title>New Small and Medium Sized Enterprises Join TI Pharma by Signing Two New Projects</title>
				<description>LEIDEN, The Netherlands, July 6 /PRNewswire/ -- Three new small and medium sized enterprises (SMEs) - Syncom, Synvolux
Therapeutics and InteRNA Technologies - have joined public-private
partnership...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3330</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3330</guid>
				<pubDate>Mon, 06 Jul 2009 12:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Supportive Care in Cancer: Palonosetron Recommended 5-HT3 Antagonist for Emesis Prevention by MASCC/ESMO</title>
				<description>LUGANO, Switzerland, June 30 /PRNewswire/ -- About Palonosetron (Aloxi(R), Onicit(R), Paloxi(R))

    Palonosetron (palonosetron hydrochloride) is a selective 5-HT3 receptor
antagonist, developed for...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3307</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3307</guid>
				<pubDate>Tue, 30 Jun 2009 13:52:00 +0000</pubDate>
			</item>
					<item>
				<title>Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab(R) Systems for the Cost-Efficient Development of Biopharmaceuticals</title>
				<description>UPPSALA, Sweden, June 29 /PRNewswire/ -- Gyros AB, the leading provider of automated micro-immunoassays for
therapeutic protein development, announces that it has raised SEK 80 million
(approximately...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3296</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3296</guid>
				<pubDate>Mon, 29 Jun 2009 10:19:00 +0000</pubDate>
			</item>
					<item>
				<title>ONGLYZA(TM) (saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes</title>
				<description>PARIS and LONDON, June 25 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (LSE: AZN) today
announced that their marketing authorisation application for...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3283</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3283</guid>
				<pubDate>Thu, 25 Jun 2009 17:31:00 +0000</pubDate>
			</item>
					<item>
				<title>O2h and Hypoxium Announce an Agreement to Offer Hypoxium&#039;s Specialised In Vitro, Cell-Based Oncology Assays via O2h&#039;s Biology Affiliate Program</title>
				<description>CAMBRIDGE, England, June 25 /PRNewswire/ -- O2h has initiated a networked approach towards being a full
service discovery services company at the forefront of drug discovery
research. O2h has...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3280</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3280</guid>
				<pubDate>Thu, 25 Jun 2009 12:14:00 +0000</pubDate>
			</item>
					<item>
				<title>BRAHMS, Cezanne and Lumiphore Announce Partnership for Diagnostic Tests</title>
				<description>BERLIN, NIMES, France and RICHMOND, California, June 22 /PRNewswire/ -- Diagnostics company BRAHMS Aktiengesellschaft, Cezanne and Lumiphore
Inc., a biotechnology leader from California, announced...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3257</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3257</guid>
				<pubDate>Mon, 22 Jun 2009 15:00:00 +0000</pubDate>
			</item>
					<item>
				<title>NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM)</title>
				<description>SAN MATEO, California and STAINES, England, June 22 /PRNewswire/ -- NeurogesX, Inc. (NASDAQ: NGSX) and Astellas Pharma Europe
Ltd., (Astellas), the European subsidiary of Tokyo based Astellas Pharma...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3252</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3252</guid>
				<pubDate>Mon, 22 Jun 2009 12:00:00 +0000</pubDate>
			</item>
					<item>
				<title>ICON Announces Collaboration to Develop New Translational Medicine Unit at Purpose-built Hospital Facility in Manchester</title>
				<description>DUBLIN, June 16 /PRNewswire/ -- ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider
of outsourced development services to the pharmaceutical, biotechnology and
medical device industries,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3223</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3223</guid>
				<pubDate>Tue, 16 Jun 2009 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Elsevier and NextBio Sign Partnership to Enrich ScienceDirect Content, Accelerating Life Sciences, Health Sciences and Chemistry Research</title>
				<description>AMSTERDAM, June 12 /PRNewswire/ -- Elsevier today announced a new partnership agreement with NextBio,
provider of an innovative platform that enables life science researchers to
search, discover, and...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3208</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3208</guid>
				<pubDate>Fri, 12 Jun 2009 13:07:00 +0000</pubDate>
			</item>
					<item>
				<title>Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier</title>
				<description>NOVATO, California, June 9 /PRNewswire/ -- Raptor Pharmaceuticals Corp. (&quot;Raptor&quot; or the &quot;Company&quot;) (OTC Bulletin
Board: RPTP), today announced that it has entered a collaboration and
licensing...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3182</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3182</guid>
				<pubDate>Tue, 09 Jun 2009 11:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Dutch Medical Equipment Producer Nucletron Strengthens Leading Position in Cancer Radiation Therapy Market</title>
				<description>VEENENDAAL, The Netherlands, June 2 /PRNewswire/ -- Nucletron BV, the innovative cancer radiation solutions company, today
announced the creation of an exclusive partnership and plan to merge...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3145</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3145</guid>
				<pubDate>Tue, 02 Jun 2009 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Boehringer Ingelheim and the World Stroke Organization Announce Partnership in the World Stroke Academy</title>
				<description>INGELHEIM, Germany, May 27 /PRNewswire/ -- Boehringer Ingelheim announced today that it will become the founding
sponsor of the World Stroke Academy, a novel training initiative for...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3116</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3116</guid>
				<pubDate>Wed, 27 May 2009 11:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Beactica Announces Drug Discovery Agreement With Cubist Pharmaceuticals</title>
				<description>UPPSALA, Sweden, May 26 /PRNewswire/ -- Beactica AB, the Swedish fragment-based drug discovery company, today
announced that it has entered into an agreement with Cubist Pharmaceuticals,
Inc....</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3103</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3103</guid>
				<pubDate>Tue, 26 May 2009 09:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies</title>
				<description>OXFORD, England, May 18 /PRNewswire/ -- Oxford BioTherapeutics (OBT) today announced a strategic
alliance with GlaxoSmithKline to discover, develop and commercialise novel,
therapeutic antibodies for...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3061</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3061</guid>
				<pubDate>Mon, 18 May 2009 07:30:00 +0000</pubDate>
			</item>
					<item>
				<title>The Institut Pasteur and M</title>
				<description>PARIS, May 18 /PRNewswire/ -- The Institut Pasteur and M</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3059</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3059</guid>
				<pubDate>Mon, 18 May 2009 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>CPM Resource Center and The Shams Group Partner To Help Hospitals Integrate Evidence-Based Clinical Content Into Information Systems</title>
				<description>GRAND RAPIDS, Michigan, May 12 /PRNewswire/ -- CPM Resource Center (CPMRC) and The Shams Group (TSG) have partnered to
provide small- and medium-sized hospitals with next-generation nursing...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3039</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3039</guid>
				<pubDate>Tue, 12 May 2009 10:25:00 +0000</pubDate>
			</item>
					<item>
				<title>Ticketmaster Proudly Working With Two UK Charities</title>
				<description>LONDON, May 7 /PRNewswire/ -- Ticketmaster UK Ltd, a Ticketmaster Entertainment, Inc. (NASDAQ:TKTM)
company, is pleased to announce the launching of two charity partnerships
with Nordoff-Robbins...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3016</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3016</guid>
				<pubDate>Thu, 07 May 2009 11:50:00 +0000</pubDate>
			</item>
					<item>
				<title>Jubilant Enters Research Collaboration With AstraZeneca</title>
				<description>NOIDA, India, May 5 /PRNewswire/ -- Jubilant Organosys Ltd, headquartered in India, announced
today that its Bangalore, India, based subsidiary,Jubilant Biosys Ltd, has
signed a research...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2997</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2997</guid>
				<pubDate>Tue, 05 May 2009 08:49:00 +0000</pubDate>
			</item>
					<item>
				<title>Cellectricon and BioFocus DPI Advance High Throughput ion Channel Drug Discovery</title>
				<description>GOTHENBURG, Sweden, April 27 /PRNewswire/ -- Cellectricon, a leading provider of automated screening solutions for
drug discovery, today announced its collaboration with BioFocus DPI, a
contract...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2947</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2947</guid>
				<pubDate>Mon, 27 Apr 2009 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Comic Relief Invests GBP6.3m to Tackle Malaria</title>
				<description>LONDON, April 23 /PRNewswire/ -- Just days ahead of World Malaria Day 2009 Comic Relief has awarded
GBP6.3m in funding to Malaria Consortium and the Global Fund to help protect
over 1m people in...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2939</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2939</guid>
				<pubDate>Thu, 23 Apr 2009 10:00:00 +0000</pubDate>
			</item>
					<item>
				<title>GSK and Pfizer Innovative Agreement Creates Specialist HIV Company</title>
				<description>LONDON, April 16 /PRNewswire/ -- Pharmaceutical companies GlaxoSmithKline and Pfizer today announced an
&quot;innovative agreement&quot; to pool their HIV assets creating a new world-leading,
specialist HIV...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2892</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2892</guid>
				<pubDate>Thu, 16 Apr 2009 12:48:00 +0000</pubDate>
			</item>
					<item>
				<title>BioDuro and Roche Expand Strategic Collaboration to Provide Drug Discovery Services</title>
				<description>BEIJING, April 6 /PRNewswire/ -- BioDuro announced today that they have entered into a strategic
partnership with Roche to support discovery phase research efforts at Roche&#039;s
global research sites....</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2846</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2846</guid>
				<pubDate>Mon, 06 Apr 2009 23:36:00 +0000</pubDate>
			</item>
					<item>
				<title>Elsevier and Brain Mapping Foundation Co-Host 6th Annual World Congress of IBMISPS on Brain Mapping and Image Guided Therapy</title>
				<description>AMSTERDAM, April 6 /PRNewswire/ -- Elsevier, the world-leading publisher of scientific, technical and
medical information products and services and Brain Mapping Foundation,
announced today that it...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2840</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2840</guid>
				<pubDate>Mon, 06 Apr 2009 11:18:00 +0000</pubDate>
			</item>
					<item>
				<title>Helsinn and T</title>
				<description>LUGANO, Switzerland and DUBLIN, April 2 /PRNewswire/ -- Helsinn together with the Irish T</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2835</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2835</guid>
				<pubDate>Thu, 02 Apr 2009 17:05:00 +0000</pubDate>
			</item>
					<item>
				<title>Promoting Environmental Health Interventions: International Medical Corps and Earth Council Geneva Launch Strategic Partnership</title>
				<description>LOS ANGELES and GENEVA, Switzerland, April 2 /PRNewswire/ -- In an effort to find sustainable solutions to global environmental health
problems International Medical Corps and Earth Council Geneva...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2831</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2831</guid>
				<pubDate>Thu, 02 Apr 2009 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>The American Medical Association and Elsevier Join to Co-Publish ICD-9-CM and HCPCS Coding Reference Books</title>
				<description>CHICAGO and ST. LOUIS, Missouri, March 31 /PRNewswire/ -- Two of the biggest names in health care publishing, the American Medical
Association (AMA) and Elsevier have announced an exclusive agreement...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2815</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2815</guid>
				<pubDate>Tue, 31 Mar 2009 16:03:00 +0000</pubDate>
			</item>
					<item>
				<title>World Heart Federation, Daiichi Sankyo and Lilly Partner to Improve Cardiovascular Health</title>
				<description>ORLANDO, Florida, March 31 /PRNewswire/ -- The World Heart Federation, Daiichi Sankyo Company, Limited (TSE: 4568)
and Eli Lilly and Company (NYSE: LLY) announced today that they have
partnered to...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2810</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2810</guid>
				<pubDate>Tue, 31 Mar 2009 09:34:00 +0000</pubDate>
			</item>
					<item>
				<title>Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD</title>
				<description>PHILADELPHIA, March 31 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today announced a co-promotion agreement with
GlaxoSmithKline plc (NYSE:...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2808</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2808</guid>
				<pubDate>Tue, 31 Mar 2009 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Stallergenes Signs an Exclusive Partnership Agreement With Solvay Pharmaceuticals for the Promotion and Distribution of its Products in Russia and the CIS*</title>
				<description>ANTONY, France, March 24 /PRNewswire/ -- Stallergenes S.A. and Solvay Pharmaceuticals Marketing and
Licensing AG (subsidiary of Solvay Group) announce the signing of an
exclusive partnership...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2768</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2768</guid>
				<pubDate>Tue, 24 Mar 2009 17:54:00 +0000</pubDate>
			</item>
					<item>
				<title>BioDuro and AstraZeneca Expand Collaboration to Optimize Discovery Research for Respiratory and Inflammation Indications</title>
				<description>BEIJING, March 23 /PRNewswire/ -- BioDuro and AstraZeneca announced today that they have expanded their
research collaboration to optimize discovery research for Respiratory and
Inflammation...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2752</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2752</guid>
				<pubDate>Mon, 23 Mar 2009 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Merck Serono and Fast Forward, LLC Announce Collaboration to Accelerate Development of Treatments for Multiple Sclerosis</title>
				<description>GENEVA, Switzerland, March 18 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt Germany, and Fast
Forward, LLC, a wholly-owned subsidiary of the American National Multiple
Sclerosis...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2723</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2723</guid>
				<pubDate>Wed, 18 Mar 2009 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>DocCheck Cooperates With European Medical Association</title>
				<description>COLOGNE, Germany, March 17 /PRNewswire/ -- Whether for doctor hopping or medical tourism, Europe is becoming
increasingly important for health care. As a result, the German doctors&#039;
portal DocCheck...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2717</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2717</guid>
				<pubDate>Tue, 17 Mar 2009 10:28:00 +0000</pubDate>
			</item>
					<item>
				<title>Simbionix Increases Product Offerings for OB/GYN Physicians</title>
				<description>CLEVELAND and ZURICH, Switzerland, March 11 /PRNewswire/ -- Simbionix, the world&#039;s leading developer of medical simulation systems,
and VirtaMed, a Swiss medical engineering company, announced today...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2698</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2698</guid>
				<pubDate>Wed, 11 Mar 2009 10:33:00 +0000</pubDate>
			</item>
					<item>
				<title>OPC Connectivity Between TruBio Software and Nova FLEX Analyzers</title>
				<description>SANTA CLARA, California, March 5 /PRNewswire/ -- Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement
and control solutions for bioprocess applications, and Nova...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2673</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2673</guid>
				<pubDate>Thu, 05 Mar 2009 23:10:00 +0000</pubDate>
			</item>
					<item>
				<title>Elsevier Announces Launch of Osteopathic Family Physician Publishing Partnership Formed With American College of Osteopathic Family Physicians</title>
				<description>ST. LOUIS, Missouri, March 4 /PRNewswire/ -- Elsevier, world-leading publisher of scientific, technical and medical
information products and services, is pleased to announce the July 2009
launch of a...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2663</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2663</guid>
				<pubDate>Wed, 04 Mar 2009 09:40:00 +0000</pubDate>
			</item>
					<item>
				<title>Epistem Announces Research and Development Collaboration With a Major Pharmaceutical Company</title>
				<description>MANCHESTER, England, March 2 /PRNewswire/ -- Epistem Plc (LSE:EHP) the UK biotechnology and research
services company announced today that they have signed a research and
development collaboration...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2640</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2640</guid>
				<pubDate>Mon, 02 Mar 2009 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Merck Serono and Ambrx Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance</title>
				<description>GENEVA, February 24 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany,
and Ambrx Inc, today announced a global strategic collaboration to develop
and commercialize Ambrx&#039;s...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2605</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2605</guid>
				<pubDate>Tue, 24 Feb 2009 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Health Robotics Expands i.v.STATION(TM) Partnership With Can-Med in 10 Countries Within Central Asia</title>
				<description>BOZEN, Italy, February 23 /PRNewswire/ -- Health Robotics and Can-Med today announced that they have signed a
definitive agreement whereby Can-Med has acquired the exclusive distribution
rights to...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2597</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2597</guid>
				<pubDate>Mon, 23 Feb 2009 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis</title>
				<description>LEUVEN, Belgium and LUND, Sweden, February 23 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR) and co-development
partner BioInvent International (OMXS: BINV) announce today that the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2593</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2593</guid>
				<pubDate>Mon, 23 Feb 2009 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Eisai and Bial Announce Partnership Agreement for the European Commercialisation of the Novel Once Daily Anti-Epileptic Zebinix(R)</title>
				<description>LONDON, February 19 /PRNewswire/ -- Eisai Europe Ltd (London; Chairman &amp;amp; CEO Yutaka Tsuchiya), the
European subsidiary of Eisai Co., Ltd. (Tokyo, President &amp;amp; CEO: Haruo Naito),
and...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2579</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2579</guid>
				<pubDate>Thu, 19 Feb 2009 15:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Vaccine Against the Chikungunya Virus in Development by a Public-Private Partnership</title>
				<description>LEIDEN, The Netherlands, February 4 /PRNewswire/ -- Top Institute Pharma (TI Pharma) has formed a consortium with Wageningen
University, Erasmus University Medical Centre and Nobilon, a subsidiary...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2519</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2519</guid>
				<pubDate>Wed, 04 Feb 2009 14:36:00 +0000</pubDate>
			</item>
					<item>
				<title>NHS Confederation Agrees Outsourcing Partnership With BIS Ltd</title>
				<description>LONDON, February 2 /PRNewswire/ -- &quot;Due to the greater effectiveness we are able to realise through our 
outsourcing partnership with BIS, the NHS Confederation has been able to 
deliver a range of...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2504</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2504</guid>
				<pubDate>Mon, 02 Feb 2009 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Fujirebio Diagnostics and Abbott Agree To Develop New Ovarian Cancer Test for Abbott&#039;s Architect(R) Analyzers</title>
				<description>MALVERN, Pennsylvania and ABBOTT PARK, Illinois, January 27 /PRNewswire/ -- Fujirebio Diagnostics, Inc. and Abbott have signed a license agreement to
develop a new ovarian cancer test for use on...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2480</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2480</guid>
				<pubDate>Tue, 27 Jan 2009 15:14:00 +0000</pubDate>
			</item>
					<item>
				<title>SurgiCare Signs Agreement With BMI Hospital Group</title>
				<description>MANCHESTER, England, January 20 /PRNewswire/ -- Leading cosmetic surgery company SurgiCare has announced an agreement
with BMI Healthcare, the UK&#039;s largest private hospital group, which...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2437</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2437</guid>
				<pubDate>Tue, 20 Jan 2009 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>ICTPH Partners With University of Pennsylvania, School of Nursing to Enhance Rural Health</title>
				<description>HYDERABAD, India, January 16 /PRNewswire/ -- To increase access to healthcare services and improve health
outcomes for rural populations, IKP Centre for Technologies in Public Health
(ICTPH) has...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2426</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2426</guid>
				<pubDate>Fri, 16 Jan 2009 09:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Wonky Wheels Create Havoc for the Weekly Shop</title>
				<description>LONDON, January 15 /PRNewswire/ -- You&#039;ve got a big grocery shop to do, the supermarket is packed, the kids
are getting restless and on top of this, you&#039;ve picked a trolley with wonky
wheels. Well...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2422</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2422</guid>
				<pubDate>Thu, 15 Jan 2009 13:46:00 +0000</pubDate>
			</item>
					<item>
				<title>Beactica Announces Fragment-Based Drug Discovery Research Collaboration With GE Healthcare and Uppsala University</title>
				<description>UPPSALA, Sweden, January 13 /PRNewswire/ -- Beactica AB, the Swedish fragment-based drug discovery company, today
announced a new research collaboration agreement with GE Healthcare (Chalfont
St....</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2395</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2395</guid>
				<pubDate>Tue, 13 Jan 2009 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Biotica Strikes Significant Collaboration Deal With GlaxoSmithKline</title>
				<description>CAMBRIDGE, England, January 12 /PRNewswire/ -- Biotica Technology Limited, a privately-held biotechnology
company, announces a significant Collaboration and License Agreement with
GlaxoSmithKline to...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2382</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2382</guid>
				<pubDate>Mon, 12 Jan 2009 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>MERIAL Takes Avian Business to New Dimension</title>
				<description>DULUTH, Georgia, January 8 /PRNewswire/ -- MERIAL Limited has grown its avian business by becoming the exclusive
distributor and technical service provider of the innovative in ovo injection
systems...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2376</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2376</guid>
				<pubDate>Thu, 08 Jan 2009 20:50:00 +0000</pubDate>
			</item>
					<item>
				<title>Rowlands Pharmacy Helps Fight Obesity With Celebrity Slim&#039;s Meal Replacement Program</title>
				<description>NEWCASTLE, England, January 7 /PRNewswire/ -- Already hugely successful in Australia, Celebrity Slim&#039;s
meal-replacement programme has just been launched in the UK, and represents a
healthy,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2363</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2363</guid>
				<pubDate>Wed, 07 Jan 2009 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>FDA Cardio Renal Advisory Committee to Review Daiichi Sankyo, Lilly Drug Prasugrel</title>
				<description>TOKYO and INDIANAPOLIS, December 31 /PRNewswire/ -- Daiichi Sankyo Company, Limited (TSE: 4568) and Eli Lilly and Company
(NYSE: LLY) today confirmed that the U.S. Food and Drug...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2350</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2350</guid>
				<pubDate>Wed, 31 Dec 2008 13:50:00 +0000</pubDate>
			</item>
					<item>
				<title>ProGenTech Partners With the China CDC to Develop an Automated Molecular Diagnostic Platform and Assays</title>
				<description>EMERYVILLE, California, December 18 /PRNewswire/ -- ProGenTech Limited, a life science and molecular diagnostics company
based in Shanghai, China and the San Francisco Bay Area has signed...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2328</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2328</guid>
				<pubDate>Thu, 18 Dec 2008 18:21:00 +0000</pubDate>
			</item>
					<item>
				<title>&quot;Making Connections&quot; A new Programme to Enhance Scientific Collaborations Between the UK and Israel</title>
				<description>LONDON, December 18 /PRNewswire/ -- Top-level research institutions in the UK and Israel will
collaborate, thanks to a bold new initiative of Weizmann UK.

    The programme - entitled &quot;Making...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2323</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2323</guid>
				<pubDate>Thu, 18 Dec 2008 11:39:00 +0000</pubDate>
			</item>
					<item>
				<title>Joint Development of Vaccines Against Avian Flu: AmVac AG Cooperates With National Health Research Institutes in Taiwan</title>
				<description>ZUG, Switzerland, December 12 /PRNewswire/ -- Swiss AmVac AG establishes comprehensive collaboration with the
National Health Research Institutes in Taiwan to combat H5N1. H5N1/Influenza
A is a flu...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2295</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2295</guid>
				<pubDate>Fri, 12 Dec 2008 12:40:00 +0000</pubDate>
			</item>
					<item>
				<title>Expansion of Product Portfolio: Prionics Enters Strategic Partnership With Ingenasa</title>
				<description>ZURICH, December 3 /PRNewswire/ -- Prionics, a world leader in farm animal diagnostics, has entered into a
strategic partnership with the Spanish company Ingenasa to make their
innovative farm animal...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2240</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2240</guid>
				<pubDate>Wed, 03 Dec 2008 13:24:00 +0000</pubDate>
			</item>
					<item>
				<title>Cellectricon Partners With The Automation Partnership - Bringing Next Generation Ion Channel Screening System to Market</title>
				<description>GOTHENBURG, Sweden, December 3 /PRNewswire/ -- Cellectricon, a leading provider of screening solutions for drug
discovery, today announced the signing of a collaborative agreement with The
Automation...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2238</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2238</guid>
				<pubDate>Wed, 03 Dec 2008 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Aetna Appointed by Department of Health to the PBC Development Framework</title>
				<description>LONDON, December 2 /PRNewswire/ -- Aetna (NYSE: AET) announced today that it has been appointed by the
Department of Health as one of five suppliers on the Practice Based
Commissioners (PBC)...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2233</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2233</guid>
				<pubDate>Tue, 02 Dec 2008 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Elsevier&#039;s EMBASE.com Partners With QUOSA</title>
				<description>AMSTERDAM, December 1 /PRNewswire/ -- EMBASE(R), Elsevier&#039;s biomedical and pharmaceutical abstract and indexing
database, today announced that it has partnered with QUOSA(TM) to enable
mutual...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2219</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2219</guid>
				<pubDate>Mon, 01 Dec 2008 09:11:00 +0000</pubDate>
			</item>
					<item>
				<title>Kiadis Pharma Announces Continued Collaboration With Professor Velardi on its Lead Product ATIR(TM)</title>
				<description>AMSTERDAM, November 28 /PRNewswire/ -- Oncology focused biopharmaceutical company Kiadis Pharma announces today
that Andrea Velardi, M.D., Professor of Clinical Immunology at the University
of...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2211</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2211</guid>
				<pubDate>Fri, 28 Nov 2008 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist</title>
				<description>LUGANO, Switzerland, November 27 /PRNewswire/ -- Helsinn Healthcare&#039;s Top management today announced that it has signed a
partnering agreement with Zealand Pharma, for the development and...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2208</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2208</guid>
				<pubDate>Thu, 27 Nov 2008 09:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Harvard Medical School and Cellectricon Collaborates Around Whole-Genome RNAi Screening Technology - Cellaxess(R)HT</title>
				<description>GOTHENBURG, Sweden, November 25 /PRNewswire/ -- Cellectricon, a leading provider of automated screening solutions for
drug discovery, today announced its collaboration with Harvard Medical
School,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2193</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2193</guid>
				<pubDate>Tue, 25 Nov 2008 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Health Robotics Announces $60M Investment by Devon International Group and ITOCHU Inc. in the CytoCare(TM) and i.v.Station(TM PENDING) Robots</title>
				<description>BOZEN, Italy, November 21 /PRNewswire/ -- Health Robotics today announced that it has signed a definitive agreement
with Devon International Group (DIG) and its strategic partner...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2184</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2184</guid>
				<pubDate>Fri, 21 Nov 2008 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>ChemDiv and Avineuro Extend Collaboration on Alzheimer&#039;s Disease and Schizophrenia</title>
				<description>SAN DIEGO, November 21 /PRNewswire/ -- ChemDiv Inc. and Avineuro Pharmaceuticals Inc. have extended the term of
their research and development collaboration including formulation, safety
and early...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2181</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2181</guid>
				<pubDate>Fri, 21 Nov 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Stem Cell Sciences Signs Service Agreement With Pfizer to Provide Access to Proprietary Technologies and Methods</title>
				<description>CAMBRIDGE, England, November 20 /PRNewswire/ -- Stem Cell Sciences plc (AIM:STEM, ASX:STC), a company focused on the
commercialisation of stem cells and stem cell technologies, has signed a
Master...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2172</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2172</guid>
				<pubDate>Thu, 20 Nov 2008 12:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Movea&#039;s MotionPod Secures First Partnership in Healthcare Sector</title>
				<description>LONDON, November 19 /PRNewswire/ -- Movea, experts in motion capture technology, have created the MotionPod,
a revolutionary microsensor device for healthcare and sports, which is able
to record,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2164</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2164</guid>
				<pubDate>Wed, 19 Nov 2008 15:48:00 +0000</pubDate>
			</item>
					<item>
				<title>E6 Ventures Wins Investment for Spin Out Company, Diamond Detectors</title>
				<description>ASCOT, England, November 17 /PRNewswire/ -- Diamond Detectors Ltd, a subsidiary company set up by Element Six to
manufacture innovative diamond detectors and sensors for radiation...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2142</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2142</guid>
				<pubDate>Mon, 17 Nov 2008 09:07:00 +0000</pubDate>
			</item>
					<item>
				<title>Record Number of Youth Dancing Worldwide to Take a Stand Against HIV and AIDS</title>
				<description>AMSTERDAM, November 17 /PRNewswire/ -- More than 50.000 young people will take a stand on the 29th of November
during Dance4Life events in 19 countries. The worldwide Dance4Life movement
is growing...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2141</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2141</guid>
				<pubDate>Mon, 17 Nov 2008 08:05:00 +0000</pubDate>
			</item>
					<item>
				<title>Oslo and Toulouse Cancer Clusters Join Forces to Drive European Cancer Research Forward</title>
				<description>OSLO, TOULOUSE, France and PARIS, November 13 /PRNewswire/ -- Oslo Cancer Cluster today signed a groundbreaking strategic
agreement with the Toulouse Canc</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2127</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2127</guid>
				<pubDate>Thu, 13 Nov 2008 13:15:00 +0000</pubDate>
			</item>
					<item>
				<title>Stem Cell Sciences Enters into Services Agreement with Huntingdon&#039;s Disease Research Group, CHDI Foundation Inc.</title>
				<description>CAMBRIDGE, England, November 10 /PRNewswire/ -- Stem Cell Sciences plc (AIM:STEM, ASX:STC), a company focused on the
commercialisation of stem cells and stem cell technologies, announces that it
has...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2086</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2086</guid>
				<pubDate>Mon, 10 Nov 2008 13:47:00 +0000</pubDate>
			</item>
					<item>
				<title>Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test</title>
				<description>OSLO and FOSTER CITY, California, November 10 /PRNewswire/ -- DiaGenic ASA (OSL: DIAG) and Applied Biosystems Inc. (NYSE: ABI) today
announced the launch of BCtect(TM), a blood-based test for early...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2075</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2075</guid>
				<pubDate>Mon, 10 Nov 2008 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Therapure Biopharma Inc. Announces Collaboration With BioVectra Inc.</title>
				<description>TORONTO and CHARLOTTETOWN, Canada, November 4 /PRNewswire/ -- BioVectra Inc. and Therapure BioPharma Inc. have agreed to partner in the 
development of a PEGylated biologic drug target used for...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2048</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2048</guid>
				<pubDate>Tue, 04 Nov 2008 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Therapure Biopharma Inc. Announces Collaboration With Induce Biologics Inc.</title>
				<description>TORONTO, Canada, October 28 /PRNewswire/ -- Thomas Wellner, President and CEO of Therapure BioPharma Inc. and Dr. 
Cameron Clokie, President and CEO of Induce Biologics Inc. today announced 
a...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2001</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/2001</guid>
				<pubDate>Tue, 28 Oct 2008 13:45:00 +0000</pubDate>
			</item>
					<item>
				<title>Nerviano Medical Sciences Announces a New Collaboration Agreement With Genentech to Discover Antibody Drug Conjugates</title>
				<description>NERVIANO, Italy, October 21 /PRNewswire/ -- Nerviano Medical Sciences (NMS), the largest pharmaceutical
R&amp;amp;D facility in Italy and one of the leading oncology-focused, integrated
discovery and...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1944</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1944</guid>
				<pubDate>Tue, 21 Oct 2008 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Baxa Ltd Launches ZR(R) Pre-Filled Saline Flush Syringes</title>
				<description>BRACKNELL, England, October 14 /PRNewswire/ -- Baxa Ltd announces its launch of a new line of pre-filled saline IV
syringes in the UK. Baxa Ltd, an organisation committed to increasing patient
safety...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1909</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1909</guid>
				<pubDate>Tue, 14 Oct 2008 09:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Radi Medical Systems AB and GE Healthcare Announce Cooperation to Integrate FFR and PressureWire(R) Aeris in GE Mac-Lab(R) IT</title>
				<description>UPPSALA, Sweden and WAUKESHA, Wisconsin, October 13 /PRNewswire/ -- Radi Medical Systems AB and GE Healthcare announced today a development;
marketing and sales initiative to integrate Radi Medical...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1906</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1906</guid>
				<pubDate>Mon, 13 Oct 2008 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Genmab Reaches Milestone in Ofatumumab Collaboration</title>
				<description>COPENHAGEN, Denmark, October 10 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today it has reached the sixth milestone
for ofatumumab (HuMax-CD20(R)) under the terms of its collaboration...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1899</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1899</guid>
				<pubDate>Fri, 10 Oct 2008 16:06:00 +0000</pubDate>
			</item>
					<item>
				<title>Stallergenes Partners With Catalent and the Medical House for Commercialization of Adrenaline Autoinjector in Europe</title>
				<description>ANTONY, France, October 7 /PRNewswire/ -- Stallergenes S.A. today announced that they have entered into
an exclusive agreement with Catalent for the promotion and distribution in
Europe of adrenaline...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1877</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1877</guid>
				<pubDate>Tue, 07 Oct 2008 17:54:00 +0000</pubDate>
			</item>
					<item>
				<title>UNICEF and Pampers Announce Partnership Aimed at Eliminating Deadly Disease by 2012</title>
				<description>GENEVA, October 2 /PRNewswire/ -- A global review confirms that the elimination of maternal and newborn
tetanus, preventable diseases responsible for the death of one baby
approximately every three...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1846</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1846</guid>
				<pubDate>Thu, 02 Oct 2008 13:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation</title>
				<description>STOCKHOLM, October 2 /PRNewswire/ -- Athera Biotechnologies AB and Dyax Corp. (NASDAQ:DYAX) announced today
that they have entered into a collaboration to discover and to develop
therapeutic products...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1845</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1845</guid>
				<pubDate>Thu, 02 Oct 2008 12:30:00 +0000</pubDate>
			</item>
					<item>
				<title>ChemBridge Corporation Enters Into New Discovery Chemistry Strategic Alliance With AstraZeneca</title>
				<description>SAN DIEGO, September 24 /PRNewswire/ -- ChemBridge Corporation today announced new multi-year research
collaboration in discovery chemistry with AstraZeneca. This new alliance
follows the previous...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1795</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1795</guid>
				<pubDate>Wed, 24 Sep 2008 12:00:00 +0000</pubDate>
			</item>
					<item>
				<title>St. Joseph&#039;s Hospital and InNexus Biotechnology Enter Collaborative Partnership</title>
				<description>PHOENIX and BRITISH COLUMBIA, Canada, September 19 /PRNewswire/ -- St. Joseph&#039;s Hospital and Medical Center, part of Catholic Healthcare
West, one of the largest healthcare systems in the West with...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1765</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1765</guid>
				<pubDate>Fri, 19 Sep 2008 14:20:00 +0000</pubDate>
			</item>
					<item>
				<title>Global Psychiatrists Unite to Improve Services in Mental Health</title>
				<description>INNSBRUCK, Austria, September 19 /PRNewswire/ -- Thirty seven medical experts in psychiatry from across the
world have called on the medical community to take urgent action to optimize
services for...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1760</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1760</guid>
				<pubDate>Fri, 19 Sep 2008 09:00:00 +0000</pubDate>
			</item>
					<item>
				<title>GlaxoSmithKline and Cellzome Announce Major Strategic Alliance</title>
				<description>LONDON and CAMBRIDGE, England and PHILADELPHIA and HEIDELBERG, Germany, September 10 /PRNewswire/ -- Cellzome Inc. and GlaxoSmithKline (LSE &amp;amp; NYSE: GSK) announce the signing
of a worldwide...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1694</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1694</guid>
				<pubDate>Wed, 10 Sep 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Nucletron Announces Advances in Image-Guided Adaptive Brachytherapy Technology for Gynecologic Cancers Through Partnership With AKH / MUW Vienna</title>
				<description>VEENENDAAL, Netherlands, September 9 /PRNewswire/ -- Nucletron, a knowledge-based leader in radiation oncology, and the
world-class medical institution General Hospital Vienna (AKH) /...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1682</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1682</guid>
				<pubDate>Tue, 09 Sep 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Movianto Supports Pinnacle Biologics&#039; Market Entry Into Europe</title>
				<description>STUTTGART, Germany, September 4 /PRNewswire/ -- Pinnacle Biologics has appointed Movianto to provide exclusive logistics
and distribution services to support the launch of the drug Ethyol(R)...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1631</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1631</guid>
				<pubDate>Thu, 04 Sep 2008 09:37:00 +0000</pubDate>
			</item>
					<item>
				<title>Merck Serono and Ablynx Enter Into an Agreement to Co-Discover and Co-Develop Nanobodies(R)</title>
				<description>GENEVA, September 4 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany,
today announced that it has entered into an agreement with Ablynx (Euronext
Brussels: ABLX), to...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1629</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1629</guid>
				<pubDate>Thu, 04 Sep 2008 06:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Merck Serono and ZymoGenetics Restructure Partnership</title>
				<description>GENEVA, Switzerland, September 3 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and
ZymoGenetics, Inc. (NASDAQ: ZGEN), Seattle, United States, today announced...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1619</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1619</guid>
				<pubDate>Wed, 03 Sep 2008 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel</title>
				<description>MUNICH, Germany, September 3 /PRNewswire/ -- A sub-analysis of the TRITON-TIMI 38 clinical trial showed that treatment
with prasugrel compared with clopidogrel significantly reduced the risk of
new...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1618</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1618</guid>
				<pubDate>Wed, 03 Sep 2008 08:16:00 +0000</pubDate>
			</item>
					<item>
				<title>San Francisco Bay Area Cell Analysis Company Forges Partnership With Hudson Control Group as First Step in Automation Initiative to Support Drug Discovery Research</title>
				<description>HAYWARD, California, August 28 /PRNewswire/ -- Guava Technologies, Inc. announced the commencement of an agreement with
Hudson Control Group to provide drug discovery researchers with an...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1593</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1593</guid>
				<pubDate>Thu, 28 Aug 2008 18:41:00 +0000</pubDate>
			</item>
					<item>
				<title>Peakdale Molecular Launches AssayReady4U(TM) in Collaboration With ChemPrintCo LLC</title>
				<description>CHAPEL-EN-LE-FRITH, England and MILPITAS, California, August 27 /PRNewswire/ -- Peakdale Molecular Ltd (CHAPEL-EN-LE-FRITH, UK) a leading
provider in specialist chemistry services to the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1577</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1577</guid>
				<pubDate>Wed, 27 Aug 2008 09:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA</title>
				<description>SAN DIEGO and INDIANAPOLIS, August 27 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company
(NYSE: LLY) in a conference call today provided context and...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1572</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1572</guid>
				<pubDate>Wed, 27 Aug 2008 00:35:00 +0000</pubDate>
			</item>
					<item>
				<title>Genmab Reaches Fifth Milestone in Ofatumumab Collaboration</title>
				<description>COPENHAGEN, August 21 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today it has reached the fifth milestone
for ofatumumab (HuMax-CD20(R)) under the terms of its collaboration with
GlaxoSmithKline...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1553</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1553</guid>
				<pubDate>Thu, 21 Aug 2008 15:22:00 +0000</pubDate>
			</item>
					<item>
				<title>Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events</title>
				<description>TOKYO and INDIANAPOLIS, August 21 /PRNewswire/ -- A new, pre-specified analysis of the landmark Phase III head-to-head
TRITON-TIMI 38 study showed patients who took prasugrel for acute...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1551</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1551</guid>
				<pubDate>Thu, 21 Aug 2008 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Bavarian Nordic Announces Partnership With National Cancer Institute in the US and Obtains Rights to a New Vaccine Candidate</title>
				<description>KVISTGARD, Denmark, August 13 /PRNewswire/ -- Bavarian Nordic&#039;s US subsidiary, BN ImmunoTherapeutics has entered into a
scientific partnership with the National Cancer Institute (NCI) in the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1510</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1510</guid>
				<pubDate>Wed, 13 Aug 2008 08:37:00 +0000</pubDate>
			</item>
					<item>
				<title>Bavarian Nordic Announces Partnership With National Cancer Institute in the US and Obtains Rights to a New Vaccine Candidate</title>
				<description>KVISTGARD, Denmark, August 13 /PRNewswire/ -- Bavarian Nordic&#039;s US subsidiary, BN ImmunoTherapeutics has entered into a
scientific partnership with the National Cancer Institute (NCI) in the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1527</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1527</guid>
				<pubDate>Wed, 13 Aug 2008 08:37:00 +0000</pubDate>
			</item>
					<item>
				<title>Banque Centrale Populaire Consolidates Activity Abroad With New Trade Finance Solutions From Misys</title>
				<description>LONDON, August 5 /PRNewswire/ -- Banque Centrale Populaire (BCP), one of the largest banks in Morocco, has
strengthened its trade finance offer to corporates with the new trade finance
solutions from...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1484</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1484</guid>
				<pubDate>Tue, 05 Aug 2008 08:36:00 +0000</pubDate>
			</item>
					<item>
				<title>GeoVax Partners with Vivalis for Use of Its Revolutionary EBx(R) Technology to Manufacture Its MVA HIV/AIDS Vaccine</title>
				<description>ATLANTA and NANTES, France, July 22 /PRNewswire/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta based,
biopharmaceutical company developing human vaccines for diseases caused by
HIV-1...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1428</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1428</guid>
				<pubDate>Tue, 22 Jul 2008 06:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Comprehensive Care International and SHI Consulting Announce Partnership for Effective Integration of Research Into Clinical Planning and Design</title>
				<description>TORONTO, July 21 /PRNewswire/ -- Comprehensive Care International (CCI) and SHI
Consulting Inc. (SHI) outlined their vision to create a sustainable
operational advantage for hospitals worldwide....</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1425</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1425</guid>
				<pubDate>Mon, 21 Jul 2008 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Physicians Practice and Nevada Cancer Institute Partner to Improve Patient Care</title>
				<description>BALTIMORE, July 15 /PRNewswire/ -- Physicians and patients of community-based medical practices in Nevada 
and SW Utah will benefit from a new partnership between Physicians 
Practice(R), America&#039;s...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1397</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1397</guid>
				<pubDate>Tue, 15 Jul 2008 17:27:00 +0000</pubDate>
			</item>
					<item>
				<title>Ingenuity Systems and CHDI Announce Multi-Year Deal for Disease-Specific Knowledge Platform</title>
				<description>REDWOOD CITY, California, July 15 /PRNewswire/ -- Ingenuity Systems, the leading provider of information solutions for life
science researchers, and CHDI Foundation, Inc., a non-profit...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1394</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1394</guid>
				<pubDate>Tue, 15 Jul 2008 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>AMT Starts Collaboration With St. Jude Children&#039;s Research Hospital on Gene Therapy for Hemophilia B. Company Accesses Exclusive Commercial Rights to Final Therapy</title>
				<description>AMSTERDAM, The Netherlands, July 15 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in
the field of human gene therapy, today announced the start of a collaboration
with...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1390</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1390</guid>
				<pubDate>Tue, 15 Jul 2008 06:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Cellectis and Regeneron Sign an Agreement Over the use of Homologous Recombination Technology</title>
				<description>BIOCITECH, France, July 3 /PRNewswire/ -- Cellectis SA today announced the signature of an agreement
with Regeneron Pharmaceuticals, Inc. over the use of Cellectis&#039; patents
covering certain uses of...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1347</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1347</guid>
				<pubDate>Thu, 03 Jul 2008 17:00:00 +0000</pubDate>
			</item>
					<item>
				<title>The Institut de la Vision and Iris Pharma Join Forces to Strengthen the Bond Between the Private and Public Sectors, and Between Industry and Academic Research</title>
				<description>NICE, France, July 3 /PRNewswire/ -- The Institut de la Vision, a research center exclusively dedicated to eye
diseases, has been the industry&#039;s benchmark on vision-related issues since
its opening...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1342</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1342</guid>
				<pubDate>Thu, 03 Jul 2008 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Genmab Reaches Milestone in Ofatumumab Collaboration</title>
				<description>COPENHAGEN, June 30 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today it has reached a development
milestone for ofatumumab (HuMax-CD20(R)) under the terms of its collaboration
with...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1324</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1324</guid>
				<pubDate>Mon, 30 Jun 2008 18:27:00 +0000</pubDate>
			</item>
					<item>
				<title>Elsevier Announces Agreement With Portico</title>
				<description>AMSTERDAM, June 26 /PRNewswire/ -- Elsevier, a leading publisher of scientific, technical and medical (STM)
information, today announced an agreement with Portico, a not-for-profit
digital...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1305</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1305</guid>
				<pubDate>Thu, 26 Jun 2008 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics</title>
				<description>REHOVOT, Israel and JERSEY CITY, New Jersey, June 25 /PRNewswire/ -- Rosetta Genomics, Ltd. (Nasdaq: ROSG), announced today a
collaboration with the Rabin Medical Center in Israel to...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1293</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1293</guid>
				<pubDate>Wed, 25 Jun 2008 13:30:00 +0000</pubDate>
			</item>
					<item>
				<title>ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody</title>
				<description>LEUVEN, Belgium, LUND, Sweden and BASEL, Switzerland, June 18 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR) and BioInvent
International AB (Nordic Exchange: BINV) announce that they have...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1232</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1232</guid>
				<pubDate>Wed, 18 Jun 2008 06:00:00 +0000</pubDate>
			</item>
					<item>
				<title>MSD Signs Partnership With BMJ Group</title>
				<description>BERLIN, June 17 /PRNewswire/ -- The pharmaceutical company MSD (known as Merck Sharp &amp;amp; Dohme Limited in
the UK and Merck &amp;amp; Co., Inc. in the US) and BMJ (British Medical Journal)
Group today...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1224</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1224</guid>
				<pubDate>Tue, 17 Jun 2008 12:26:00 +0000</pubDate>
			</item>
					<item>
				<title>AmVac AG Begins Research Cooperation With Bayer Research Laboratory Inaugurated in Catania</title>
				<description>ZUG, Switzerland and CATANIA, Italy, June 12 /PRNewswire/ -- AmVac AG, a Swiss biopharmaceutical company based in Zug, is
starting its first research cooperation program with Bayer Innovation GmbH...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1194</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1194</guid>
				<pubDate>Thu, 12 Jun 2008 08:53:00 +0000</pubDate>
			</item>
					<item>
				<title>Mentice Initiates Collaboration With Pieter Stella as Clinical Advisor</title>
				<description>GOTHENBURG, June 12 /PRNewswire/ -- Mentice, a leading developer of medical simulation solutions, today
announces collaboration with Dr. Pieter Stella as Clinical Advisor to
Mentice. Dr Stella will...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1191</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1191</guid>
				<pubDate>Thu, 12 Jun 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse</title>
				<description>TOKYO and NEW DELHI, India, June 11 /PRNewswire/ -- Daiichi Sankyo Company, Limited (TSE: 4568.JP) (&quot;Daiichi Sankyo&quot;), one of
the largest pharmaceutical companies in Japan, and Ranbaxy...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1187</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1187</guid>
				<pubDate>Wed, 11 Jun 2008 11:10:00 +0000</pubDate>
			</item>
					<item>
				<title>Merck Serono Strengthens its Prescription Medicines Portfolio in Latin America</title>
				<description>GENEVA, Switzerland, June 10 /PRNewswire/ -- Merck Serono (NYSE: SRA), a division of Merck KGaA, Darmstadt, Germany,
announced today the signing of a distribution agreement with Bristol-Myers
Squibb...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1178</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1178</guid>
				<pubDate>Tue, 10 Jun 2008 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Ingenuity Systems Announces Multi-Year Agreement With Boehringer Ingelheim</title>
				<description>REDWOOD CITY, California, June 3 /PRNewswire/ -- Ingenuity Systems, the leading provider of information solutions for life
science researchers, announced the signing of a four year agreement...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1137</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1137</guid>
				<pubDate>Tue, 03 Jun 2008 11:00:00 +0000</pubDate>
			</item>
					<item>
				<title>ThromboGenics and BioInvent Report Positive Phase I Results for Anti-PlGF Cancer Therapeutic TB-403</title>
				<description>LEUVEN, Belgium and LUND, Sweden, June 3 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR) and co-development
partner BioInvent International AB (Nordic Exchange: BINV) today reported
that...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1134</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1134</guid>
				<pubDate>Tue, 03 Jun 2008 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Kiadis Pharma Announces Collaboration With the Julius Maximilians University of Würzburg, Germany</title>
				<description>AMSTERDAM, May 29 /PRNewswire/ -- Biopharmaceutical company Kiadis Pharma announces today the clinical
development collaboration for its lead product ATIR(TM) with Dr. Stephan
Mielke and Professor...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1091</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1091</guid>
				<pubDate>Thu, 29 May 2008 10:40:00 +0000</pubDate>
			</item>
					<item>
				<title>World Gastroenterology Organisation and Danone launch Global Campaign to Improve Digestive Health</title>
				<description>LONDON, May 29 /PRNewswire/ -- Today, on the occasion of World Digestive Health Day (WDHD), the World
Gastroenterology Organisation (WGO) has launched a year-long campaign titled
&#039;Optimum Health and...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1089</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1089</guid>
				<pubDate>Thu, 29 May 2008 00:01:00 +0000</pubDate>
			</item>
					<item>
				<title>AMT&#039;s Cooperative Research and Development Agreement with NIH to Boost Production Capacity</title>
				<description>AMSTERDAM, The Netherlands, May 26 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in
the field of human gene therapy, today announced that it obtained a
Cooperative...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1067</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1067</guid>
				<pubDate>Mon, 26 May 2008 06:00:00 +0000</pubDate>
			</item>
					<item>
				<title>University Hospitals Case Medical Center, Cleveland, USA and Cardialysis BV, Rotterdam, the Netherlands Enter Strategic Alliance to Found Cardialysis Cleveland</title>
				<description>CLEVELAND, Illinois and ROTTERDAM, The Netherlands, May 9 /PRNewswire/ -- University Hospitals Case Medical Center and Cardialysis BV today
announced that the Companies have the intention to found...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/956</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/956</guid>
				<pubDate>Fri, 09 May 2008 07:35:00 +0000</pubDate>
			</item>
					<item>
				<title>NTT Europe Online and Sun Start-Up Essentials Help Deliver Glasses Direct to Customers</title>
				<description>LONDON, April 25 /PRNewswire/ -- Glasses Direct has signed up as a member and customer of the
hosting offer in the Sun Start-Up Essentials program in the UK. As part of
the program, the online...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/865</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/865</guid>
				<pubDate>Fri, 25 Apr 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&amp;amp;D Partnership</title>
				<description>LAS VEGAS, April 24 /PRNewswire/ -- CardioVascular BioTherapeutics, Inc. (OTC Bulletin Board: CVBTE) has
entered into an agreement with Mr. Phillip Frey Jr. to form Cardio Derma
Clinical Partners...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/856</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/856</guid>
				<pubDate>Thu, 24 Apr 2008 13:00:00 +0000</pubDate>
			</item>
					<item>
				<title>SCHOTT Forms Pharmaceutical Joint Venture in India</title>
				<description>MAINZ, Germany and MUMBAI, India, April 24 /PRNewswire/ -- SCHOTT AG and KAISHA Manufacturers Private Ltd., an Indian company,
announce the formation of a joint venture, SCHOTT KAISHA Private Ltd....</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/852</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/852</guid>
				<pubDate>Thu, 24 Apr 2008 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>ESBATech&#039;s Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications</title>
				<description>ZURICH, Switzerland, April 24 /PRNewswire/ -- ESBATech AG, a leading developer of antibody fragment therapeutics, today
announced the initiation of Phase I clinical development of the company&#039;s
lead...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/851</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/851</guid>
				<pubDate>Thu, 24 Apr 2008 06:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Agendia and Agilent Announce Plans to Jointly Develop New Diagnostic Tests, Extend Supply Agreement</title>
				<description>AMSTERDAM, Netherlands and SANTA CLARA, California, April 22 /PRNewswire/ -- Agendia BV, a world leader in the rapidly evolving field of molecular
diagnostics, and Agilent Technologies, Inc. (NYSE:...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/834</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/834</guid>
				<pubDate>Tue, 22 Apr 2008 14:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Global Med Technologies(R), Inc. and Cerner Announce Strategic Alliance</title>
				<description>DENVER, April 9 /PRNewswire/ -- Global Med Technologies(R), Inc. (OTC Bulletin Board: GLOB), an
international e-Health, medical information technology company, today
announced that its Wyndgate...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/753</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/753</guid>
				<pubDate>Wed, 09 Apr 2008 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Health Unions React to NHS Pay Offer</title>
				<description>LONDON, April 8 /PRNewswire/ -- Health unions representing 200,000 healthcare scientists, health
visitors, speech and language therapists, clinical psychologists, chaplains,
mental health nurses,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/749</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/749</guid>
				<pubDate>Tue, 08 Apr 2008 14:07:00 +0000</pubDate>
			</item>
					<item>
				<title>Shire and TAP Agree to Co-promote LIALDA(TM) (Mesalamine), the First Oral Once-Daily Mesalamine for Patients With Active, Mild to Moderate Ulcerative Colitis</title>
				<description>BASINGSTOKE, England and PHILADELPHIA, March 26 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announced today a co-promotion agreement with...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/619</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/619</guid>
				<pubDate>Wed, 26 Mar 2008 17:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Perot Systems and ChinaSoft to Pursue Chinese Healthcare Opportunities</title>
				<description>PLANO, Texas, March 18 /PRNewswire/ -- Perot Systems Corporation (NYSE: PER) and ChinaSoft International
(HK8216) today announced that they have agreed to cooperatively develop
mutually beneficial...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/588</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/588</guid>
				<pubDate>Tue, 18 Mar 2008 09:30:00 +0000</pubDate>
			</item>
					<item>
				<title>Misys and Allscripts Create a Leader in Healthcare Software</title>
				<description>LONDON, March 18 /PRNewswire/ -- In a video interview Mike Lawrie, CEO Misys, and Glen Tullman, CEO
Allscripts, talk about the combination of Misys Healthcare and Allscripts to
create a leader in US...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/587</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/587</guid>
				<pubDate>Tue, 18 Mar 2008 07:36:00 +0000</pubDate>
			</item>
					<item>
				<title>Misys and Allscripts Create a Leader in Healthcare Software</title>
				<description>LONDON, March 18 /PRNewswire/ --     In a video interview Mike Lawrie, CEO Misys, and Glen Tullman, CEO
Allscripts, talk about the combination of Misys Healthcare and Allscripts to
create a leader in...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/719</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/719</guid>
				<pubDate>Tue, 18 Mar 2008 07:36:00 +0000</pubDate>
			</item>
					<item>
				<title>Spize TV Partners Pyramid Saimira</title>
				<description>LONDON, March 14 /PRNewswire/ --     
    - Launches DTH Services Across Europe, North Africa &amp;amp; Middle East

</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/710</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/710</guid>
				<pubDate>Fri, 14 Mar 2008 14:38:00 +0000</pubDate>
			</item>
					<item>
				<title>Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery</title>
				<description>LONDON, March 13 /PRNewswire/ --     
    Silence Therapeutics plc (AIM: SLN) today announces a collaboration with
AstraZeneca (LSE: AZN), focused on the development of a range of novel
approaches...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/700</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/700</guid>
				<pubDate>Thu, 13 Mar 2008 15:56:00 +0000</pubDate>
			</item>
						<atom:link href="http://pharmalicensing.com/public/public/news/newsmlrss/270/Joint_Ventures" rel="self" type="application/rss+xml" />
	</channel>
</rss>
